Results of newborn screening for galactose metabolic disorders.
A screening strategy has been used which uses the Paigen and Beutler methods for the determination of galactose and galactose-1-phosphate. A blood spot test for epimerase has also been developed. In the last 10 years, 265,019 samples from newborns have been tested by these methods. Among the 154 screening positives, we have detected seven cases of epimerase-deficient galactosaemia (Type III), seven cases of Duarte/galactosaemia heterozygotes, 48 cases of other various types of heterozygotes, four cases of persistent hypergalactosaemia, three cases of hepatitis and one case of congenital atresia of the bile duct. These results indicate that our screening system has effectively detected the infants with galactose metabolic disorders.
Inoue
B
B
Okayama Prefectural Institute for Environmental Science and Public Health, Japan.
Hata
M
M
Ichiba
Y
Y
Wada
H
H
Misumi
H
H
Mori
T
T
D002239:Carbohydrate Metabolism, Inborn Errors / Q000097:blood / Q000235:genetics / Q000517:prevention & control*; D005690:Galactose / Q000378:metabolism*; D005693:Galactosemias / Q000097:blood / Q000235:genetics / Q000517:prevention & control; D005695:Galactosephosphates / Q000097:blood; D006580:Genetic Carrier Screening; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening / Q000379:methods; D014534:UDPglucose 4-Epimerase / Q000097:blood / Q000172:deficiency
D005695:Galactosephosphates; C029973:galactose-1-phosphate; D014534:UDPglucose 4-Epimerase; D005690:Galactose